Malaria Worldwide
Vectors
Malaria Classification
Drug Resistant Malaria
Malaria Aetiology
Clinical Presentation
Diagnosis
Care of Malaria Patient
Traveller's Information
History
Epidemiology
Vectors
Human Host
Uncomplicated Malaria
Complicated Malaria
Typical Presentation
Relapse & Recrudescence
Complications
By the Doctor
In the Laboratory
Morphology
Artemether + Lumefantrine
Artesunate + Amodiaquine
Artesunate + Sulfadoxine & Pyrimethamine
β Arteether
α / β Arteether
Artemether
Quinine
Sulfadoxine + Pyrimethamine
Amodiaquine
Mefloquine
Chloroquine
Primaquine
Links
Slides
i.
http://mosquito.who.int/
ii.
http://www.rph.wa.gov.au/labs/haem/malaria/index.html
iii.
http://www.mmv.org
iv.
http://www.malaria.org
v.
http://www.malariasite.com
vi.
http://who.int/topics/malaria/en
vii.
http://cdc.gov/malaria
viii.
http://www.who.int/tdr/diseases/malaria/
ix.
http://www.mim.su.se/
x.
http://www.vnh.org/Malaria/Malaria.html
xi.
http://www.malariajournal.com/
xii.
http://www.malariavaccine.org/
xiii.
http://www.malariaandhealth.com/
xiv.
http://www.med.monash.edu.au/microbiology/malaria/who.html
xv.
http://www.actmalaria.org/
xvi.
http://www.niaid.nih.gov/dmid/malaria/
xvii.
http://www.unicef.org/health/index_malaria.html
xviii.
http://www.usaid.gov/our_work/global_health/id/malaria/
xix.
http://www.mosquito-control.net/
xx.
http://www.nlm.nih.gov/mimcom/mimcomhome.html
Supported by
Ipca Laboratories Ltd.
Leaders in Antimalarials
designed & developed by
Aniktantra